Software & SaaS

As community hubs face new threats, advanced AI surveillance offers powerful protection. But what are the costs and ethical lines for Canadian organizations?

Beyond webinars, ON24's G2 win and LinkedIn pact reveal a strategic shift to AI-driven data and connected campaigns in the B2B marketing tech war.

Nomentia appoints a new CEO with a mandate for international growth, signaling a major shift in the competitive landscape of treasury management technology.

With a key FAA filing, Electra's hybrid-electric EL9 moves closer to reality, promising to bypass airports with 150-foot takeoffs and landings.

A Hong Kong award for Youxin Technology offers a deeper look into the firm's strategic acquisition, its role in the GBA, and what it means for investors.

The space firm secures vital cash through a complex warrant deal, but at what cost to shareholders? All eyes are now on a critical investor vote.

With new clinical data and recent FDA approval, IceCure Medical's tumor-freezing tech is paving a new, less-invasive path for breast cancer treatment.

NiCE's local data center launch in South Africa is more than a new product; it's a strategic play on compliance and advanced AI to capture the continent.

A new partnership signals a shift towards versatile, American-made drone systems, streamlining critical missions and challenging market incumbents.

The ESA's new elite summit, iicon, replaces E3, targeting C-suites to leverage gaming tech across healthcare, finance, and media. What's at stake?

A German tech firm's new platform offers a real-time map of grid capacity, aiming to solve a critical hurdle in North America's energy transition.

Early Phase 1 data for VTP-1000 shows promise, but can this novel immunotherapy challenge a crowded market and change life for 80 million patients?

As Sharebite brings its meal platform to the UK, it’s not just about perks. It’s a strategic play for productivity, retention, and the future of work.

A new, fully customizable quantum system promises to democratize R&D, fueling national strategies and accelerating discovery in science and medicine.

Glean's new research institute and context-aware agents offer a pragmatic path for businesses struggling to operationalize AI safely and effectively.

CodeSignal's new AI interviews candidates by phone in 20+ languages, promising a revolution in efficiency. But can it overcome the hurdles of bias and empathy?

A new partnership between Telix and Varian aims to fuse precision diagnostics with adaptive radiotherapy, a strategic move set to disrupt the cancer care market.

India's new Labour Code 2025 is forcing a strategic pivot. Discover how firms are turning regulatory mandates into a competitive edge for productivity.

With $47.5M and a veteran CEO, PsiThera is using its advanced AI platform to develop oral medicines for diseases long-dominated by injectable biologics.

Professor Youmin Xi's recent honor signals more than academic success. It marks a strategic blueprint for cultivating the next generation of life science leaders.